Immix Biopharma's total assets for Q4 2025 were $104.84M, an increase of 422.10% from the previous quarter. IMMX total liabilities were $11.04M for the fiscal quarter, a -6.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.